Berlin: Researchers at Greifswald Teaching Hospital in northern Germany said on Friday they had discovered the cause of the unusual blood clot problems found in some recipients of the AstraZeneca coronavirus vaccine, the public broadcaster reported. Norddeutscher Rundfunk (NDR).
Research showed how the vaccine caused blood clots in the brain in some patients. The discovery means that a specific treatment can be developed to prevent problems.
The success was the result of cooperation between Greifswald Hospital, the state health regulator at the Paul Ehrlich Institute (PEI), and also doctors in Austria: a nurse died of a thrombosis in the brain after be vaccinated with the AstraZeneca puncture.
The researchers stressed that treatment would only be possible in patients where blood clots appear, rather than as a preventative treatment.
The information has been shared with hospitals across Europe.
AstraZeneca returns to the track in Europe
Germany, as well as several other EU member states, suspended the use of the AstraZeneca vaccine on Monday after reports of unusual blood clots.
On Thursday, the European Medicines Agency (EMA) said there were no proven links between the vaccine and blood clots, according to the information they had. They also claimed that the benefits of the puncture outweighed the possible risks.
On Friday, Germany should restart vaccines with the English-Swedish puncture. On Thursday Germany had administered more than 10 million doses of COVID-19 vaccines, including the AstraZeneca vaccine.